![]() |
RELATED RESOURCES |
SEC Filings:NRIXNURIX THERAPEUTICS INC12.01
|
Year | Type ![]() |
![]() |
Period End Date | |
---|---|---|---|---|
2022 | Form SC 13G | Beneficial Ownership Statement | 06/10/2022 | N/A |
Form 4 | Insider Transaction | 06/01/2022 | 05/31/2022 | |
Form 8-K* | Current Report* | 05/26/2022 | 05/26/2022 | |
Form 8-K* | Current Report* | 05/16/2022 | 05/15/2022 | |
Form 4 | Insider Transaction | 05/06/2022 | 05/05/2022 | |
Form 4 | Insider Transaction | 05/06/2022 | 05/05/2022 | |
Form 4 | Insider Transaction | 05/06/2022 | 05/05/2022 | |
Form 4 | Insider Transaction | 05/06/2022 | 05/05/2022 | |
Form 4 | Insider Transaction | 05/06/2022 | 05/05/2022 | |
Form 4 | Insider Transaction | 05/06/2022 | 05/05/2022 | |
Form 8-K* | Current Report* | 05/06/2022 | 05/05/2022 | |
Form 10-Q* | Quarterly Report* | 04/08/2022 | 02/28/2022 | |
Form 8-K* | Current Report* | 04/07/2022 | 04/07/2022 | |
Form DEF 14A | Definitive Proxy Statements | 03/25/2022 | 05/05/2022 | |
Form DEFA14A | Definitive Proxy Statements | 03/25/2022 | N/A |